LAVA Therapeutics NV Stock, NASDAQ:LVTX
Yalelaan 60, Utrecht, Noord-Brabant 3584 CM
Number of Employees: 58
LAVA Therapeutics NV operates as an immuno-oncology company. It utilizing its proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.